| Literature DB >> 24942688 |
Hyeseon Cho1, Brian L Kelsall.
Abstract
Type I interferons are a widely expressed family of effector cytokines that promote innate antiviral and antibacterial immunity. Paradoxically, they can also suppress immune responses by driving production of anti-inflammatory cytokines, and dysregulation of these cytokines can contribute to host-mediated immunopathology and disease progression. Recent studies describe their anti-inflammatory role in intestinal inflammation and the locus containing IFNAR, a heterodimeric receptor for the type I interferons has been identified as a susceptibility region for human inflammatory bowel disease. This review focuses on the role of type I IFNs in the intestine in health and disease and their emerging role as immune modulators. Clear understanding of type I IFN-mediated immune responses may provide avenues for fine-tuning existing IFN treatment for infection and intestinal inflammation. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: enteric microbial infection; intestinal inflammation; type I interferons
Mesh:
Substances:
Year: 2014 PMID: 24942688 PMCID: PMC4551418 DOI: 10.1111/imr.12195
Source DB: PubMed Journal: Immunol Rev ISSN: 0105-2896 Impact factor: 12.988